| Gene symbol | TG | Synonyms | AITD3, TGN | Type of gene | protein-coding |
| Chromosome | 8 | Map location | 8q24.22 | dbXrefs | |
| Description | thyroglobulin | ||||
| GTO ID | GTC1516 |
| Trial ID | NCT02390739 |
| Disease | Thyroid Cancer |
| Altered gene | TG |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | Thyroglobulin TCR-T cells |
| HLA | HLA-A*02:01 |
| Phase | Phase1|Phase2 |
| Recruitment status | Withdrawn |
| Title | Phase I/II Study Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to Patients With Thyroglobulin Expressing Thyroid Cancer |
| Year | 2015 |
| Country | United States |
| Company sponsor | National Cancer Institute (NCI) |
| Other ID(s) | 150090|15-C-0090 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||
|
|||||||